Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupoint Application for Knee Osteoarthritis Pain
NCT05449613Phase 3Unknown
- Sponsor
- Guang'anmen Hospital
- Start
- Oct 2021
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Visual Analog Scale Pain Score at 4 weeks. Status: unknown.
02
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05449613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05449613.